News The latest developments in autism research.
Profiles Portraits of scientists who are making a mark on autism research.
Toolbox Emerging tools and techniques that may advance autism research.
Spotted A roundup of autism papers and media mentions you may have missed.
Opinion Conversations on the science of autism research.
Viewpoint Expert opinions on trends and controversies in autism research.
Columnists Dispatches from experts on various facets of autism.
Crosstalk Debates and conversations about timely topics in autism.
Reviews Exploring the intersection of autism and the arts.
Q&A Conversations with experts about noteworthy topics in autism.
Deep Dive In-depth analysis of important topics in autism.
Special Reports Curated collections of articles on special topics in autism.
Webinars Presentations by leading experts on their latest research.
Features / Webinars

Lisa Croen discusses autism in adults

30 April 2014
The Presenter
Presenter

Lisa Croen

Director, Autism Research Program, Kaiser Permanente

On 30 April, Lisa Croen presented findings from her investigation of a large population of adults with autism. She broke down the frequencies of co-occurring medical conditions in this well-characterized population, and patterns of healthcare usage.

She also suggested how these data can help to improve the lives of individuals with autism transitioning into adulthood. Croen is director of the Autism Research Program at Kaiser Permanente, a healthcare consortium based in Oakland, California.

You can watch a complete replay of the webinar above.

Use the comments section below to submit questions we didn’t have time to discuss during the Q&A session or to pose follow-up questions for Croen.

 

Press Policy
The Spectrum Webinar Series aims to facilitate the free exchange of ideas among autism researchers, including discussion of published and unpublished research, hypotheses and results. Members of the press may report information presented during a Spectrum webinar only if that material has already been published elsewhere or they have first obtained express written consent from the presenter.

About Webinars
Presentations by leading experts that showcase new findings, useful techniques and emerging topics in autism research. We invite questions before and during the presentations in the Comments section.
  • RA Jensen

    I missed the presentation but was able to listen the next day. I know that Kaiser looks at the children and adults within the Kaiser network. How has Covered California worked to identify and cover people with ASD who had no insurance coverage before the ACA and when will you be able to measure the success of Covered California in reaching out to the previously uninsured, especially adults with ASD. Success? I hope so.

  • Marian O’Brien

    Can you make the slides available? Thank you.

    • gregboustead

      Hi Marian,

      We currently don’t distribute the actual slides; sharing the slides is at the discretion of the presenter. The complete replay (above), however, will remain freely available as an archive on our site for reference and sharing with colleagues.

      Thanks for participating in the webinar,
      Greg

  • Michael Baron, MBE

    I was one of the 6 founders of the UK National Autistic Society in 1962 and a parent of a 57 year old man. I am writing a chapter with my daughter (Ex BBC documentary producer etc of TV film The Autism Puzzle in 2003. I have a particular interest in ageing and autism and have given several talks on the issues (as has my daughter on related sibling issues). I am in Oakland with my partner over Xmas next. Any chance of a meeting ?

  • Michael Baron, MBE

    I SHOULD HAVED ADDED THAT I WOULD LIKE TO MEET UP WITH DR LIZA CROEN

  • James Fahey, Aspergers Victoria (Australia)

    Pity that antipsychotic usage was not broken down into typical and atypical. Since the data shows the use of antipsychotics is around three times the rate of those who actually report psychosis, I’m surprised it was not seen worthwhile to question the numbers taking atypical antipsychotics off-label for non-psychotic conditions. Not delineating the various diagnoses (ASD, Asperger’s, Autistic Disorder) is also unhelpful, as, while there may be similarities, there are also considerable differences in behaviours (amongst other things) between these groups.

close

Log in to your Spectrum Wiki account

Email Address:

Password:


close

Request your Spectrum Wiki account

Spectrum Wiki is a community of researchers affiliated with an academic or research institutions. To be considered for participation, please fill out this form and a member of our team will respond to your request.

Name:

Email Address:

Title and Lab:

Area of Expertise:

Comments: